Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome: A Double-blind, Randomized, Placebo-controlled Trial

NCT06722534 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT06722534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06722534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome: A Double-blind, Randomized, Placebo-controlled Trial
Lead sponsor
Air Force Military Medical University, China
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2025
Completion date
January 1, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celecoxib, peutz-jeghers syndrome, small bowel polyp